Latest Gleevec news
Many Online Pharmacies Sell Imatinib Without Prescription
posted August 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Cost Savings Limited With Generic Imatinib
posted May 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
Prices of imatinib (Gleevec) remained high even after a generic version was introduced, according to a report published in the May issue of Health Affairs.
Lasting Outcomes for Imatinib in Chronic Myeloid Leukemia
posted March 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
For patients with newly diagnosed chronic myeloid leukemia, treatment with imatinib is associated with an estimated overall survival rate of 83.3 percent at 10 years, according to a study published in the March 9 issue of the New England Journal of Medicine.
Millions in Health Costs Will Be Saved by Generic Gleevec
posted March 18th
by modernClinician Editorial Team
by modernClinician Editorial Team
Using the generic version of the cancer drug Gleevec could save patients and insurers millions of dollars, according to a study published online March 4 in the Journal of the National Cancer Institute.
Editor's Recommendations
Acute Myeloid Leukemia Increasingly Impacting Older Adults Globally 
Cancer-Attributable Costs High for Seniors, Vary With Cancer Phase, Type, Race 
Mental Distress, Fatigue Common in Childhood Survivors of Leukemia, Lymphoma 
RYGB, Sleeve Gastrectomy Cost-Effective for Teens With Severe Obesity 
PPARγ Antagonist Imatinib Improves Insulin Sensitivity 
FDA Approves First Generic Version of Gleevec Monthly Specialist Briefings
Stay Connected
